Panacea Biotec Ltd (PANACEABIO) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 622974, "name": "Panacea Biotec", "stock_name": "Panacea Biotec", "full_name": "Panacea Biotec Ltd", "name_url": "stocks-analysis/panacea-biotec", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "325.00", "chg": 2.95, "chgp": "0.92%", "dir": 1, "prev_price": "322.05", "mcapval": "2,022.00 Cr", "mcap": "Small Cap", "scripcode": 531349, "symbol": "PANACEABIO", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "indexname": "India SENSEX", "isin": "INE922B01023", "curr_date": "Apr 10", "curr_time": "", "bse_nse_vol": "93.61 k", "exc_status": "Active", "traded_date": "Apr 10, 2026", "traded_date_str": "2026 04 10", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/panacea-biotec-622974-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "Panacea Biotec Ltd is Rated Strong Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/panacea-biotec-ltd-is-rated-strong-sell-3939453", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/PanaceaBiotecLt_mojoScore_3939453.png", "date": "2026-04-09 10:10:18", "description": "Panacea Biotec Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 31 Oct 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 09 April 2026, providing investors with the latest insights into its performance and outlook." }, { "title": "Panacea Biotec Ltd Gains 1.06%: 4 Key Factors Driving the Weekly Move", "link": "https://www.marketsmojo.com/news/stocks-in-action/panacea-biotec-ltd-gains-106-4-key-factors-driving-the-weekly-move-3932195", "imagepath": "", "date": "2026-04-04 16:07:08", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>30 Mar:</strong> New 52-week low (Rs.295.75)</p>\n <p><strong>30 Mar:</strong> Intraday low hit Rs.293.1 amid heavy selling pressure</p>\n <p><strong>1 Apr:</strong> Significant gap up and intraday high at Rs.315</p>\n <p><strong>2 Apr:</strong> Week closes at Rs.322.90 (+1.06%)</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.319.50</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.322.90</div><div class=\"stat-change positive\">+1...." }, { "title": "Panacea Biotec Ltd Opens 6.37% Higher Amid Mixed Technical Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/panacea-biotec-ltd-opens-strong-with-significant-gap-up-on-1-april-2026-3927957", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/PanaceaBiotecLt_gapup_3927957.png", "date": "2026-04-01 09:34:26", "description": "" }, { "title": "Panacea Biotec Ltd Surges 7.83% to Day's High of Rs 315 — Outperforms Sector by 3.65 Percentage Points", "link": "https://www.marketsmojo.com/news/stocks-in-action/panacea-biotec-ltd-hits-intraday-high-with-783-surge-on-1-april-2026-3927925", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/PanaceaBiotecLt_priceRelatedfactors_3927925.png", "date": "2026-04-01 09:33:58", "description": "The Sensex advanced 2.7% on 1 Apr 2026, yet Panacea Biotec Ltd outpaced the broader market with a 7.83% gain, reaching an intraday high of Rs 315. This 3.65-percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers signals a distinctly stock-specific rally rather than a mere market lift." }, { "title": "Panacea Biotec Ltd Hits Intraday Low Amidst Price Pressure on 30 Mar 2026", "link": "https://www.marketsmojo.com/news/stocks-in-action/panacea-biotec-ltd-hits-intraday-low-amidst-price-pressure-on-30-mar-2026-3925429", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/PanaceaBiotecLt_priceRelatedfactors_3925429.png", "date": "2026-03-30 15:26:20", "description": "Panacea Biotec Ltd experienced a significant intraday decline on 30 Mar 2026, hitting a new 52-week low of Rs. 293.1 as the stock faced pronounced selling pressure amid broader market weakness and sector underperformance." }, { "title": "Panacea Biotec Ltd Falls to 52-Week Low of Rs 295.75 as Sell-Off Deepens", "link": "https://www.marketsmojo.com/news/stocks-in-action/panacea-biotec-ltd-falls-to-52-week-low-amid-continued-downtrend-3925578", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/PanaceaBiotecLt_priceRelatedfactors_3925578.png", "date": "2026-03-30 15:06:58", "description": "For the third consecutive session, Panacea Biotec Ltd has seen its share price decline, culminating in a fresh 52-week low of Rs 295.75 on 30 Mar 2026. This marks a significant drop of nearly 50% from its 52-week high of Rs 581, underscoring persistent selling pressure amid a challenging market backdrop." }, { "title": "Panacea Biotec Ltd is Rated Strong Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/panacea-biotec-ltd-is-rated-strong-sell-3922773", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/PanaceaBiotecLt_mojoScore_3922773.png", "date": "2026-03-29 10:10:14", "description": "Panacea Biotec Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 31 Oct 2025. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 29 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing." }, { "title": "Panacea Biotec Ltd Hits Intraday High with 7.92% Surge on 18 Mar 2026", "link": "https://www.marketsmojo.com/news/stocks-in-action/panacea-biotec-ltd-hits-intraday-high-with-792-surge-on-18-mar-2026-3898748", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/PanaceaBiotecLt_priceRelatedfactors_3898748.png", "date": "2026-03-18 11:01:10", "description": "Panacea Biotec Ltd demonstrated robust intraday performance on 18 Mar 2026, surging 7.92% to touch a day’s high of Rs 340.95. This sharp uptick outpaced the broader Sensex, which gained 0.81%, and the Pharmaceuticals & Biotechnology sector, with Panacea Biotec outperforming its sector by 6.76% during the trading session." }, { "title": "Panacea Biotec Ltd is Rated Strong Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/panacea-biotec-ltd-is-rated-strong-sell-3898525", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/PanaceaBiotecLt_mojoScore_3898525.png", "date": "2026-03-18 10:10:27", "description": "Panacea Biotec Ltd is rated 'Strong Sell' by MarketsMOJO, with this rating last updated on 31 October 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 18 March 2026, providing investors with the latest insights into the company’s performance and outlook." } ], "total": 243, "sid": "622974", "stock_news_url": "https://www.marketsmojo.com/news/panacea-biotec-622974" }, "announcements": [ { "caption": "Receipt Of Rectified Assessment Order For AY 2015-16", "datetime": "07-Apr-2026", "details": "In continuation to our letter dated 02.03.2026 we are pleased to inform you that the Deputy Commissioner of Income Tax has issued a rectified Assessment Order dated 06.04.2026. Under this order the errors have been corrected and the Companys tax liability for AY 2015-16 has been determined as Nil. A detailed disclosure as required under Regulation 30 of SEBI LODR Regulations read with SEBI Master Circular dated 30.01.2026 and Industry Standards on Regulation 30 of SEBI LODR Regulations are annexed herewith.", "source": "BSE" }, { "caption": "Demat Status Report For The Month Of March 2026", "datetime": "07-Apr-2026", "details": "We would like to inform you that no share has been dematerialised during the month of March 2026. A copy of the certificate obtained from the Companys RTA viz. Skyline Financial Services Pvt. Ltd. regarding shares dematerialised as on 31.03.2026 is enclosed herewith.", "source": "BSE" }, { "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018", "datetime": "07-Apr-2026", "details": "We are enclosing herewith a certificate dated 01.04.2026 issued by Skyline Financial Services Pvt. Ltd. Registrar and Transfer Agent of the Company confirming compliance under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018 for the quarter ended March 31 2026.", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Panacea Biotec Ltd has declared <strong>75%</strong> dividend, ex-date: 19 Sep 11", "dt": "2011-09-19", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

30 Mar: New 52-week low (Rs.295.75)

30 Mar: Intraday low hit Rs.293.1 amid heavy selling pressure

1 Apr: Significant gap up and intraday high at Rs.315

2 Apr: Week closes at Rs.322.90 (+1.06%)

Read full news article

Panacea Biotec Ltd Opens 6.37% Higher Amid Mixed Technical Signals

2026-04-01 09:34:26

Read full news article

Panacea Biotec Ltd Surges 7.83% to Day's High of Rs 315 — Outperforms Sector by 3.65 Percentage Points

2026-04-01 09:33:58

The Sensex advanced 2.7% on 1 Apr 2026, yet Panacea Biotec Ltd outpaced the broader market with a 7.83% gain, reaching an intraday high of Rs 315. This 3.65-percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers signals a distinctly stock-specific rally rather than a mere market lift.

Read full news article

Panacea Biotec Ltd Hits Intraday Low Amidst Price Pressure on 30 Mar 2026

2026-03-30 15:26:20

Panacea Biotec Ltd experienced a significant intraday decline on 30 Mar 2026, hitting a new 52-week low of Rs. 293.1 as the stock faced pronounced selling pressure amid broader market weakness and sector underperformance.

Read full news article

Panacea Biotec Ltd Falls to 52-Week Low of Rs 295.75 as Sell-Off Deepens

2026-03-30 15:06:58

For the third consecutive session, Panacea Biotec Ltd has seen its share price decline, culminating in a fresh 52-week low of Rs 295.75 on 30 Mar 2026. This marks a significant drop of nearly 50% from its 52-week high of Rs 581, underscoring persistent selling pressure amid a challenging market backdrop.

Read full news article

Panacea Biotec Ltd is Rated Strong Sell

2026-03-29 10:10:14

Panacea Biotec Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 31 Oct 2025. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 29 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Read full news article

Panacea Biotec Ltd Hits Intraday High with 7.92% Surge on 18 Mar 2026

2026-03-18 11:01:10

Panacea Biotec Ltd demonstrated robust intraday performance on 18 Mar 2026, surging 7.92% to touch a day’s high of Rs 340.95. This sharp uptick outpaced the broader Sensex, which gained 0.81%, and the Pharmaceuticals & Biotechnology sector, with Panacea Biotec outperforming its sector by 6.76% during the trading session.

Read full news article

Panacea Biotec Ltd is Rated Strong Sell

2026-03-18 10:10:27

Panacea Biotec Ltd is rated 'Strong Sell' by MarketsMOJO, with this rating last updated on 31 October 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 18 March 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article